Karamperis Nikolaos, Sloth Erik, Jensen Jens Dam
Department of Renal Medicine C, Skejby, Aarhus University Hospital, Aarhus, Denmark.
Am J Kidney Dis. 2005 Sep;46(3):470-80. doi: 10.1053/j.ajkd.2005.05.022.
It is the prevailing view that convective dialysis techniques stabilize blood pressure. Calcium concentration in the substitution fluid may be important in this respect. The aim of this study is to investigate the influence of calcium ion concentration in the substitution fluid on hemodynamic stability during predilution hemofiltration (HF).
We conducted a randomized, crossover, blinded, controlled trial with 12 stable long-term hemodialysis patients without diabetes. Each patient was randomly assigned to substitution fluid with a calcium ion (iCa) concentration of 2.5 mEq/L (1.25 mmol/L; low-calcium session [L-HF]) or 3.5 mEq/L (1.75 mmol/L; high-calcium session [H-HF]) during 4.5 hours of predilution HF with a volume of 1.24 +/- 0.09 L/kg dry body weight and a temperature of 37 degrees C. Ultrafiltration was kept constant in each patient. Blood pressure (mean, systolic [SBP], and diastolic blood pressure [DBP]), pulse rate, arterial and venous temperature, energy transfer, and relative blood volume were measured at 15-minute intervals. Cardiac output, total peripheral resistance, stroke volume, and iCa were measured hourly. The 2 treatments were matched with the exception of iCa concentration.
A significant intratreatment reduction in cardiac output and stroke volume was shown to the same extent for both groups. Intertreatment comparisons showed a significantly lower mean arterial pressure, SBP, DBP, and total peripheral resistance in the L-HF compared with the H-HF group.
iCa concentration of 3.5 versus 2.5. mEq/L (1.75 versus 1.25 mmol/L) in the infusate during predilution HF stabilized blood pressure, possibly because of greater peripheral resistance rather than through changes in cardiac performance.
目前普遍认为对流透析技术可稳定血压。在这方面,置换液中的钙浓度可能很重要。本研究的目的是探讨置换液中钙离子浓度对预稀释血液滤过(HF)期间血流动力学稳定性的影响。
我们对12例无糖尿病的稳定长期血液透析患者进行了一项随机、交叉、双盲、对照试验。在4.5小时的预稀释HF过程中,每位患者被随机分配到钙离子(iCa)浓度为2.5 mEq/L(1.25 mmol/L;低钙组[L-HF])或3.5 mEq/L(1.75 mmol/L;高钙组[H-HF])的置换液中,置换液量为1.24±0.09 L/kg干体重,温度为37℃。每位患者的超滤量保持恒定。每隔15分钟测量血压(平均压、收缩压[SBP]和舒张压[DBP])、脉搏率、动静脉温度、能量传递和相对血容量。每小时测量心输出量、总外周阻力、每搏输出量和iCa。除iCa浓度外,两种治疗方法相匹配。
两组均显示出相同程度的治疗内心输出量和每搏输出量显著降低。治疗间比较显示,与H-HF组相比,L-HF组的平均动脉压、SBP、DBP和总外周阻力显著降低。
预稀释HF期间,输注液中iCa浓度为3.5与2.5 mEq/L(1.75与1.25 mmol/L)可稳定血压,可能是因为外周阻力增加,而非心脏功能改变。